Each CRISPR/Cas9 Knockout (KO) Plasmid product consists of a pool of 3 plasmids designed to ensure identification and cleavage of a specific gene for maximum knockout efficiency. Each plasmid encodes a unique 20 nt sequence derived from the GeCKO (v2) library.
Med8 CRISPR Plasmids (h)
- Target species: human
- CRISPR/Cas9 KO Plasmids consists of Med8-specific 20 nt guide RNA sequences derived from the GeCKO (v2) library
- For CRISPR gene knockout, gRNA sequences direct the Cas9 protein to induce a site-specific double strand break (DSB) in the genomic DNA
- Target-specific CRISPR Plasmids for both gene knockout and activation are available. Please refer to the detailed product information in the tabs below
- Gene knockdown or activation can be assayed using Med8 Antibody (A-5): sc-365960
- All products are provided as transfection-ready, purified plasmid DNA, except the Lentiviral Activation Particles which have been prepackaged as Lentiviral Particles for use with hard-to-transfect cells
QUICK LINKS
Ordering Information
CRISPR/Cas9 KO Plasmid
CRISPR Activation Plasmids
Recommended Control Products
SEE ALSO...
Med8 Antibodies for analysis of cellular responses to Med8 CRISPR Products
Learn more about the CRISPR System
CRISPR/Cas9 KO plasmids, Double Nickase Plasmids and CRISPR/dCas9 Activation plasmids are considered a "Licensed Product" and are to be used in accordance with the Limited/Label License. Click here for details
Description
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Med8 CRISPR/Cas9 Knockout (KO) Plasmid (h) consists of a pool of three plasmids each encoding the Cas9 nuclease and a Med8-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency
- gRNA sequences are derived from the GeCKO (v2) library and direct the Cas9 protein to induce a site-specific double strand break (DSB) in the genomic DNA
- **** NOTE: No corresponding HDR is available for this Knockout Plasmid. **** Please use sc-404402-KO-2 and sc-404402-HDR-2 if selection of cells using puromycin resistance is desired.
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Med8 Antibody (A-5): sc-365960
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Description
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Med8 CRISPR Activation Plasmid (h) is a synergistic activation mediator (SAM) transcription activation system designed to specifically upregulate gene expression
- Med8 CRISPR Activation Plasmid (h) consists of three plasmids at a 1:1:1 mass ratio: a plasmid encoding the deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, and a blasticidin resistance gene; a plasmid encoding the MS2-p65-HSF1 fusion protein, and a hygromycin resistance gene; a plasmid encoding a target-specific 20 nt guide RNA fused to two MS2 RNA aptamers, and a puromycin resistance gene
- The resulting SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
- Following transfection, gene activation efficiency can be assayed by WB, IF or IHC using antibody: Med8 Antibody (A-5): sc-365960
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Med8 CRISPR/Cas9 KO Plasmid (h) | sc-404402 | 20 µg | $397.00 | |||
Med8 CRISPR Activation Plasmid (h) | sc-404402-ACT | 20 µg | $397.00 |